Application Nr Approved Date Route Status External Links
NDA019790 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Dilatrate ® -Sr Sustained Release Capsules Are Indicated For The Prevention Of Angina Pectoris Due To Coronary Artery Disease. The Onset Of Action Of Controlled-Release Oral Isosorbide Dinitrate Is Not Sufficiently Rapid For This Product To Be Useful In Aborting An Acute Anginal Episode.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Isosorbide Dinitrate

Comments